About Insightec
Insightec is a company based in Tirat Carmel (Israel) founded in 1999 by Oded Tamir and Kobi Vortman. Insightec has raised $574.2 million across 13 funding rounds from investors including GE Healthcare, Fidelity Investments and Baillie Gifford. Insightec offers products and services including Exablate Neuro. Insightec operates in a competitive market with competitors including HistoSonics, Profound Medical, Theraclion, SONIRE Therapeutics and Carthera, among others.
- Headquarter Tirat Carmel, Israel
- Founders Oded Tamir, Kobi Vortman
- Stage Unicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Insightec Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$574.2 M (USD)
in 13 rounds
-
Latest Funding Round
$150 M (USD), Series G
Jun 18, 2024
-
Investors
GE Healthcare
& 20 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Insightec
Insightec offers a comprehensive portfolio of products and services, including Exablate Neuro.
Platform for non-invasive treatment of Essential Tremor and Parkinson's Disease.
People of Insightec
Unlock access to complete
Unlock access to complete
Funding Insights of Insightec
Insightec has successfully raised a total of $574.2M across 13 strategic funding rounds. The most recent funding activity was a Series G round of $150 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Insightec
Insightec has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include GE Healthcare, Fidelity Investments and Baillie Gifford.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on neurotechnology for brain disorders.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Venture capital is provided to biomedical technology startups.
|
Locked | Locked | Locked |
Investor details for Insightec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Insightec
Investment portfolio details for Insightec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Insightec
Detailed financials for Insightec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Insightec Comparisons
Peer comparison for Insightec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Insightec
Insightec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HistoSonics, Profound Medical, Theraclion, SONIRE Therapeutics and Carthera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| Locked | Locked | Locked |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| Locked | Locked | Locked |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
|
| Locked | Locked | Locked |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
Detailed competitors of Insightec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Insightec
Complete news archive for Insightec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insightec
Insightec was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Insightec is headquartered in Tirat Carmel, Israel. It is registered at Tirat Carmel, Haifa District, Israel.
Kobi Vortman is the current CEO of Insightec. They have also founded this company.
Insightec is a funded company, having raised a total of $574.2M across 13 funding rounds to date.
Insightec was founded in 1999 in Tirat Carmel, Israel, as a provider of medical devices utilizing MR-interfaced ultrasound technology. The Exablate Neuro platform is employed to deliver focused sound waves guided by MRI for treating medication-refractory essential tremor, Parkinsons disease, uterine fibroids, and pain from metastatic bone tumors. Operations center on neurology and oncology sectors, with devices integrated into clinical settings for non-invasive procedures.
Insightec's top competitors include HistoSonics, Profound Medical and Theraclion.
Insightec offers Exablate Neuro.
Insightec has 21 investors. Key investors include GE Healthcare, Fidelity Investments, Baillie Gifford, Perceptive Advisors, and Koch Disruptive Technologies.
The valuation of Insightec is $1.3B as of Mar 2020.